# Transportation and Transit Services

Canonical: https://abierto.us/opportunities/75f40124r00049

- Solicitation number: 75F40124R00049
- Notice type: Special notice
- Status: Closed. Deadline was May 16, 2024 at 12:00 PM EDT
- Department: Department of Health and Human Services
- Agency: Food and Drug Administration
- Contracting office: Food and Drug Administration (n-FOODANDDRUGADMINISTRATION)
- NAICS: 485410 School and Employee Bus Transportation
- Product or service code: V119 Other Cargo and Freight Services
- Set-aside: 8(a) set-aside
- Place of performance: Silver Spring, Maryland
- County: Montgomery County (FIPS 24031). https://abierto.us/counties/montgomery-county-md-24031
- City: Silver Spring. https://abierto.us/cities/silver-spring-md-2472450
- First posted: April 18, 2024
- Last posted: April 18, 2024
- SAM.gov: https://sam.gov/workspace/contract/opp/711ffb492feb4aa392c5a902aad26eb3/view

## Description

Notice of Fair Opportunity - 8(a) After Exclusion of Sources The US Food and Drug Administration {FDA), Office of Finance Budget Acquisition and Planning, intends to issue a single award from a fair opportunity competition After Exlusion of Sources, based on a result of an RFI 75F40124R00005, issued on 10/06/23 - to provide transportation, transit, and parking related services for the Food and Drug Administration (FDA) Services on the White Oak Campus (WO), located at 10903 New Hampshire Ave, Silver Spring, Maryland 20993. The propose this acquisition After Exclusion of Sources, is for the Government to solicit and negotiate with identified source only.

Interested parties may identify their interests and capabilities, to respond to the requirement within seven (7) days after the publication of this notice. A determination by the Government not to compete this proposed acquisition, as 8(a) Set Aside - After Exclusion of Sources, based upon responses to this notice, is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining, not to conduct a set aside competitive requirement.

No further solicitation is available. FDA will consider all responses received prior to the closing date of this notice and will use responses in determining, whether it is necessary to use full and open competition for this requirement. Responses shall be emailed to Natapol Sirikhan, Natapol.Sirikhan@fda.hhs.gov, by May 16, 2024, 12:00 PM EST.

## Publications

- April 18, 2024: Special notice, due May 16, 2024 at 12:00 PM EDT. Notice 67472352f19b427cb2397156fda09262. https://sam.gov/workspace/contract/opp/67472352f19b427cb2397156fda09262/view
- April 18, 2024: Special notice, due May 16, 2024 at 12:00 PM EDT. Notice 711ffb492feb4aa392c5a902aad26eb3. https://sam.gov/workspace/contract/opp/711ffb492feb4aa392c5a902aad26eb3/view

## Points of contact

- Natapol Sirikhan, Natapol.Sirikhan@fda.hhs.gov, 2404028031

---
Source: SAM.gov Contract Opportunities bulk extract. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/75f40124r00049.